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Mitochondrial DNA toxicity in forebrain neurons causes
apoptosis, neurodegeneration, and impaired behavior
Abstract
Mitochondrial dysfunction underlying changes in neurodegenerative diseases is often associated with
apoptosis and a progressive loss of neurons, and damage to the mitochondrial genome is proposed to be
involved in such pathologies. In the present study we designed a mouse model that allows us to
specifically induce mitochondrial DNA toxicity in the forebrain neurons of adult mice. This is achieved
by CaMKIIalpha-regulated inducible expression of a mutated version of the mitochondrial UNG DNA
repair enzyme (mutUNG1). This enzyme is capable of removing thymine from the mitochondrial
genome. We demonstrate that a continual generation of apyrimidinic sites causes apoptosis and neuronal
death. These defects are associated with behavioral alterations characterized by increased locomotor
activity, impaired cognitive abilities, and lack of anxietylike responses. In summary, whereas
mitochondrial base substitution and deletions previously have been shown to correlate with premature
and natural aging, respectively, we show that a high level of apyrimidinic sites lead to mitochondrial
DNA cytotoxicity, which causes apoptosis, followed by neurodegeneration.
MOLECULAR AND CELLULAR BIOLOGY, Mar. 2010, p. 1357–1367 Vol. 30, No. 6
0270-7306/10/$12.00 doi:10.1128/MCB.01149-09
Copyright © 2010, American Society for Microbiology. All Rights Reserved.
Mitochondrial DNA Toxicity in Forebrain Neurons Causes Apoptosis,
Neurodegeneration, and Impaired Behavior
Knut H. Lauritzen,1 Olve Moldestad,2 Lars Eide,3 Harald Carlsen,4 Gaute Nesse,1 Johan F. Storm,2
Isabelle M. Mansuy,5 Linda H. Bergersen,6* and Arne Klungland1,7*
Centre for Molecular Biology and Neuroscience, Institute of Medical Microbiology, Oslo University Hospital and University of Oslo,
NO-0027 Oslo, Norway1; Department of Physiology, Institute of Basic Medical Sciences, Faculty of Medicine, University of
Oslo, Domus Medica, Sognsvannsveien 9, PB1103 Blindern, 0317 Oslo, Norway2; Institute of Clinical Biochemistry,
Oslo University Hospital and University of Oslo, Oslo, Norway3; Department of Nutrition Research, Institute of
Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway4; Brain Research Institute,
Medical Faculty of the University of Zurich and Department of Biology, Swiss Federal Institute of
Technology, Winterthurerstrasse 190, 8057 Zurich, Switzerland5; Brain and Muscle Energy Group;
Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway6; and Institute of
Basic Medical Sciences, University of Oslo, P.O. Box 1018 Blindern,
NO-0315 Oslo, Norway7
Received 26 August 2009/Returned for modification 21 November 2009/Accepted 28 December 2009
Mitochondrial dysfunction underlying changes in neurodegenerative diseases is often associated with
apoptosis and a progressive loss of neurons, and damage to the mitochondrial genome is proposed to be
involved in such pathologies. In the present study we designed a mouse model that allows us to specifically
induce mitochondrial DNA toxicity in the forebrain neurons of adult mice. This is achieved by CaMKII-
regulated inducible expression of a mutated version of the mitochondrial UNG DNA repair enzyme
(mutUNG1). This enzyme is capable of removing thymine from the mitochondrial genome. We demon-
strate that a continual generation of apyrimidinic sites causes apoptosis and neuronal death. These
defects are associated with behavioral alterations characterized by increased locomotor activity, impaired
cognitive abilities, and lack of anxietylike responses. In summary, whereas mitochondrial base substitu-
tion and deletions previously have been shown to correlate with premature and natural aging, respectively,
we show that a high level of apyrimidinic sites lead to mitochondrial DNA cytotoxicity, which causes
apoptosis, followed by neurodegeneration.
A variety of both exogenous and endogenous reactive com-
pounds present a constant threat to the integrity of DNA in
living cells. DNA damage introduced by such compounds can
lead to high and deleterious mutation rates as well as DNA
cytotoxicity, both to the nuclear and the mitochondrial ge-
nome. This has triggered the evolution of several different
DNA repair pathways (28). One is the base excision repair
(BER) pathway, which repairs small base alterations that do
not distort the DNA helix. Repair of such highly abundant
lesions by BER is performed by a multistep process that is
initiated by a damage-specific DNA glycosylase, which removes
the damaged base. One of these glycosylases is uracil-DNA
glycosylase (UDG), which acts to preserve the genome by
removing mutagenic uracil residues from the DNA. This gly-
cosylase, as well as the OGG1 glycosylase that is specialized for
the removal of oxidized bases, exists in a nuclear and mito-
chondrial splice form (1, 11, 37, 45). Accordingly, BER of a
variety of lesions has been observed in mitochondria (26, 31).
Damage to the mitochondrial DNA (mtDNA) can cause
respiratory chain deficiency and lead to disorders that have
varied phenotypes (35, 41). Many involve neurological features
that are often associated with cell loss within specific brain
regions. These pathologies, along with the increasing evidence
of a decline in mitochondrial function with aging, have raised
speculation that key changes in mitochondrial DNA sequences
and functions could have a vital role in age-related neurode-
generative diseases (41). This has also been studied in several
model organisms. Mouse models with respiratory chain defi-
cient dopamine neurons have demonstrated adult onset Par-
kinsonism phenotype (16), and cell death induced by mito-
chondrial toxicity is likely to underlie Alzheimer disease (32).
Mitochondrial oxidative stress and accumulation of mtDNA
damage are believed to be particularly devastating to postmi-
totic differentiated tissue, including neurons (30). The mtDNA
contains genetic information for 13 polypeptides that are a part
of the electron transport chain and for rRNAs and tRNAs that
are necessary for mitochondrial protein synthesis. Thus, dam-
age to the mtDNA genome will affect the energetic capacities
of the mitochondria and also influence the level of reactive
oxygen species (ROS) and ultimately the susceptibility to
apoptosis (30, 35).
Some recent influential studies have assessed the effect of
mtDNA mutagenesis, including small base-pair substitutions
and larger mtDNA deletions, on the life span of mice. It was
concluded that a massive increase in the frequency of mtDNA
base-pair substitutions are required for inducing premature
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aging, whereas the number of mtDNA deletions coincides bet-
ter with natural aging (25, 47–49).
In the present study, we have combined two novel transgenic
mouse models, which allow the induction of a high number of
apyrimidinic (AP) sites specifically to the mitochondrial ge-
nome in adults simply by the addition of doxycycline to the
diet. Such AP sites are created by the expression of a mutated
version of mitochondrion-targeted human UDG (abbreviated
here as mutUNG1), whereby an amino acid substitution results
in an enzyme that removes thymine, in addition to uracil, from
DNA (23). The CaMKII promoter restricts expression of the
mutUNG1 to forebrain neurons (34). We demonstrate that a
continuous generation of AP sites leads to apoptosis, acceler-
ated neurodegeneration, and impaired behavior.
MATERIALS AND METHODS
Transgenic constructs and mice. A pGEM7ZF plasmid containing human
UNG1 (pUNG15) was a gift from Hans Krokan (38). Site-directed mutagenesis
was carried out by using a QuikChange site-directed mutagenesis kit (Strat-
agene). The primers used in the reaction to obtain Tyr147Ala were 5-GCTTG
ATTAGGTCCATGAGCTGGATCCTGTCCCAG-3 and 5-CTGGGACAGG
ATCCAGCTCATGGACCTAATCAAGC-3. The mutUNG1 was cloned into a
pBI-L Tet vector (Clontech). Transgenic mice were generated by pronuclear
injection of the pBI-L-mutUNG1 construct using the C57BL/6 strain. Positive
founder mice were bred with transgenic mice containing the rtTA2S-M2 Tet-on
system, under the control of the CaMKII promoter (34). The presence of
mutUNG1, luciferase, and rtTA2 were verified by PCR with the following prim-
ers: mutUNG1, 5-TTAGAACCTAATTCCCAATTCCCGGACCG-3 and 5-G
CTTCTTCCAGCTCTCTCCAAAGCC-3; luciferase, 5-GTGGATCCCCCCT
AGAGTATTACAATAGC-3 and 5-TGGAGACATAGCTTACTGGGACGA
AGAC-3; and rtTA2, 5-TGCCTTTCTCTCCACAGGTGTCC-3 and 5-GAG
AGCACAGCGGAATGAC-3. Doxycycline was administered as previously
described (34). Transgenic founders were selected by investigating luciferase
expression in brains utilizing in vivo and ex vivo imaging. In vivo imaging was
performed by administering D-luciferin intraperitoneally (120 to 150 mg/kg) to
mice anesthetized with 2.5% isoflurane. Bioluminescence was recorded by the
IVIS100 imaging system (Xenogen/Caliper). Images were analyzed by Living
Image software (Xenogen/Caliper).
All experimental procedures were approved by the Section for Comparative
Medicine at the Oslo University Hospital and by the Norwegian Animal Re-
search Authority and complied with national laws and institutional regulations
governing the use of animals in research.
Cell line. The pBI-L-mutUNG1 construct was stable transfected into a HeLa
Tet-On cell line, together with a linear hygromycin marker (Clontech) by using
FuGENE 6 transfection reagent (Roche). Cells were grown in the presence of
400 g of hygromycin B (Clontech)/ml for selection. The presence of the trans-
gene was confirmed by sequencing, and the expression was based on measuring
luciferase activity, using a luciferase assay system (Promega) and a TD20/20
luminometer (Turner Designs). The stable transfected cell line was induced by
using 1 g/ml of doxycycline (Clontech).
Mitochondrial extract. Mitochondria were isolated with the Mitochondria
isolation kit (Pierce) and dissolved in a buffer containing 0.5% Igepal CA-630
(Sigma), 2 mM dithiothreitol (DTT), 1% protein inhibitor cocktail (Sigma cat-
alog no. P8340), and 0.5% Triton X-100 (Sigma) in phosphate-buffered saline
(PBS). Mitochondria were incubated on ice for 5 min and centrifuged at a
maximum speed on a table centrifuge, and the protein concentration was mea-
sured by using Bio-Rad protein assay dye reagent concentrate (Bio-Rad).
Western blot analysis. Western blot analysis was performed using NuPAGE
10% Bis-Tris gels and Invitrolon polyvinylidene difluoride membranes (Invitro-
gen). A total of 20 g of protein mitochondrial extract was applied. The presence
of UNG1 was confirmed with 2 g/ml of UNG1 antibody (ProSci, Inc.), and
anti-complex II 70-kDa Fp subunit monoclonal antibody diluted 1/1500 (Invitro-
gen) was used as a mitochondrial marker and loading control. Secondary anti-
bodies used were anti-rabbit IgG (whole molecule)–alkaline phosphatase anti-
body (Sigma catalog no. A3812), dilution of 1:30,000 or goat anti-mouse IgG-AP
(Santa Cruz Biotechnology, Inc., catalog no. sc-2008), dilution of 1:5,000, respec-
tively. Bands were visualized using ECF substrate (GE Healthcare), a Typhoon
9410, and ImageQuant TL v2003.02 software (Amersham/GE Healthcare).
RT-PCR. Freshly dissected brain tissue was homogenized by using tubes from
a FastRNA Pro Green kit (QBiogene) containing lysis buffer from a Dynabeads
mRNA Direct kit (Invitrogen) and a FastPrep Instrument (QBiogene). The
supernatant was collected, and mRNA was isolated according to the protocol of
Dynabeads mRNA Direct kit (Invitrogen). Reverse transcriptase PCR (RT-
PCR) was performed by using a Titanium one-step RT-PCR kit (Clontech), with
30 ng of RNA for each reaction. The primers 5-ATGGGCGTCTTCTGCCTT
GGGCCGT-3 and 5-AAAATACGGTTTCCCGAACTCCCCGCT-3 were
used. The annealing temperature in the PCR was set to 60°C, and 25 cycles were
used. PCR product was run on a 1% agarose gel, and bands were visualized by
using an AlphaImager (Alpha Innotech).
Preparation of substrate for oligonucleotide nicking assay. A 31-mer oligo-
nucleotide containing either a single uracil or a single thymine residue placed at
position 16 from the 5 terminus was used as a substrate; uracil-substrate, 5-G
GGGCCCGGGCCCCGUGGGCCCCGGGGCCCG-3, thymine-substrate, 5-
GGGGCCCGGGCCCCGTGGGCCCCGGGGCCCG-3 and complementary
strand 5-CGGGCCCCGGGGCCCACGGGGCCCGGGCCCC-3 (for both
substrates). All oligonucleotides included phosphorothioate linkages at the ulti-
mate and penultimate 5 and 3 residues to reduce exonucleolytic attack (MWG
Biotech AG).
The oligonucleotides were end labeled at the 5 terminus. The labeling reac-
tion contained 28 pmol of the oligonucleotide, 1.48 MBq (0.04 mCi) of
[-32P]ATP (Perkin-Elmer), 20 U of T4 polynucleotide kinase (New England
Biolabs), TSE-buffer (20 mM Tris-HCl [pH 9.5], 1 mM spermidine HCl, 0.1 mM
EDTA), and appropriate kinase buffer in a total volume of 60 l (incubation for
1 h at 37°C). End-labeled oligonucleotide substrates were separated and purified
on a denaturing 20% PAGE gel. Double molar amounts of the complementary
oligonucleotide were added to form duplex DNA substrate.
Nicking assay. UDG and TDG activity was measured in a 10-l assay mixture
containing (final) 20 mM Tris-HCl (pH 7.5), 10 mM NaCl, 1 mM EDTA, 1 mM
DTT, 1% proteinase inhibitor cocktail (Sigma), 28 nM labeled substrate, and 2.5
g of total protein (brain) extract. The samples were incubated for 30 min at
37°C, followed by the addition of 2.5 l of NaOH (0.5 M) and incubation for 20
min at 70°C. The samples were neutralized by adding 2.5 l of HCl (0.5 M). A
total of 10 l of loading buffer was added, and 10 l was run on a denaturing 20%
PAGE gel. Bands were visualized and quantified by using a Typhoon 9410 and
ImageQuant TL v2003.02 software (Amersham/GE Healthcare).
The total protein extract was made by freshly dissected mouse brain tissue that
was homogenized in a buffer containing 20 mM Tris-HCl (pH 7.5), 10 mM NaCl,
1 mM EDTA, 1 mM DTT, 1% proteinase inhibitor cocktail (Sigma), and 0.5%
Triton X-100 (Sigma). The samples were frozen on ethanol-dry ice and thawed
at 37°C; this was performed three times. The samples were then incubated on ice
for 5 min and centrifuged at maximum speed on a table centrifuge. The protein
concentration was measured by using Bio-Rad protein assay dye reagent con-
centrate.
Mutation studies. Point mutation studies of total DNA from brain tissue were
performed as described previously (47). The cytochrome B gene was PCR am-
plified by using the primers 5-TGGGGTGTTTAGTGGATTAGCTGGTAT
G-3 and 5-GGTGAAGGCTTTAATGCTAACCCAAGAC-3. PCR-amplified
mtDNA from three mutUNG1-expressing mice and three wild-type littermates
(cerebellum, hippocampus, and caudate putamen for all) were investigated. The
TOPO-cloned cytochrome B gene was sequenced completely using vector-spe-
cific M13 primers. Sequences were analyzed by using SeqScape software (Ap-
plied Biosystems).
Oxygraph. Mitochondria were isolated from freshly dissected mouse brain
tissue and purified by differential centrifugation in isolation buffer, omitting the
Percoll gradient purification step as described in the original protocol (2). The
mitochondrial suspension was transferred to an Oxygraph-2K for respiratory
analysis in Mir05 buffer (Oroboros Instruments). Complex I respiration was
obtained by combined supplement of pyruvate (5 M), malate (2 mM), and
glutamate (10 mM). Respiration capacity was determined after the addition of
ADP (1 mM), followed by saturating amounts of FCCP to completely uncouple
the mitochondria. The coupling numbers in mutUNG1-expressing mice and
wild-type littermates were statistically indifferent, and varied: 6 (cerebellum), 2
(hippocampus), and 4 (caudate putamen). Complex II-based respiration was
quantified after inhibition of complex I with rotenone (50 uM) and the addition
of succinate (10 mM) to the uncoupled mitochondria.
Paraffin sections. Whole brains were fixed in 10% (vol/vol) neutral buffered
formalin (Richard-Allan Scientific) for at least 48 h and paraffin embedded.
Brains were cut by using a Rotary microtome 355 S (Microm) into 4-m-thick
sections and dyed with hematoxylin and eosin (HE; Richard-Allan Scientific).
HE-stained sections were studied with a Zeiss Axioplan 2 microscope, and
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pictures were taken and analyzed with an AxioCamHRc and AxioVision Rel. 4.6
software.
Cryosections. Whole brains were frozen on a razorblade on dry ice. Frozen
brains were immersed in Neg50 frozen section medium (Richard-Allan Scien-
tific). An HM 550 Cryostat was used to cut the brains into 8-m-thick sections.
ARP/streptavidin staining. Cryosections were treated with biotin blocking kit
(Invitrogen) and probed with 20 mM aldehyde-reactive probe (N-(aminooxy-
acetyl)-N-(D-biotinoyl) hydrazine, trifluoroacetic acid salt (ARP; Invitrogen) for
1 h at 37°C. Then, the sections were treated with 40 g/ml of streptavidin-Alexa
Fluor 488 conjugate (Invitrogen), which recognizes the biotin tag of the ARP, for
1 h at 37°C and stained with 1 g/ml of DAPI (4,6-diamidino-2-phenylindole;
Sigma). Sections were studied with a Zeiss Axiovert 200M microscope, and
pictures were taken and analyzed with an AxioCamMRm and AxioVision Rel 4.6
software.
Immunostaining and immunohistochemistry. Cryosections were fixed in 4%
paraformaldehyde and permeabilized in 0,1% Triton X-100 (Sigma) in PBS. The
sections were blocked in 5% bovine serum albumin (BSA; Sigma), 5% goat
serum (Sigma), and 0.1% Triton X-100 (Sigma). Sections were incubated with
anti-MAP2 (Chemicon), diluted 1:500, and monoclonal anti-GFAP (Sigma),
diluted 1:400. Both antibodies were diluted in 0.5% BSA (Sigma), 0.5% goat
serum, and 0.1% Tween 20 (Sigma) in PBS. The secondary antibodies utilized
were Alexa Fluor 594-conjugated goat anti-mouse IgG (HL; Invitrogen catalog
no. A11005) and Alexa Fluor 488-conjugated goat anti-rabbit IgG (HL; In-
vitrogen catalog no. A11008). In addition, sections were incubated with 1 g/ml
of DAPI. Mowiol 4-88 reagent (Merck Biosciences, Ltd.) mounting solution and
a coverslip were applied, and the sections were studied with a Zeiss Axiovert
200M microscope. Pictures were taken and analyzed with an AxioCamMRm and
AxioVision Rel 4.6 software.
TUNEL. Apoptosis was investigated in cryosections by using an in situ cell
death detection kit, TUNEL (terminal deoxynucleotidyltransferase-mediated
dUTP-biotin nick end labeling), and TMR Red staining (Roche) according to
the manufacturer’s recommendations. In addition, sections were stained with
1 g/ml DAPI. Sections were studied with a Zeiss Axiovert 200M microscope,
and pictures were taken and analyzed with an AxioCamMRm and AxioVision
Rel 4.6 software.
Tissue preparation for electron microscopy. Hippocampus and cerebellum in
mice (sections were typically 0.5 by 0.5 by 1 mm) were cryoprotected by immer-
sion in graded concentrations of glycerol (10, 20, and 30%) in PBS. The samples
were then plunged into liquid propane cooled to 190°C by liquid nitrogen in a
Universal Cryofixation System KF80 (Reichert-Jung). For freeze substitution,
the tissue samples were immersed in a solution of anhydrous methanol and 0.5%
uranyl acetate overnight at 90°C. The temperature was then raised stepwise in
4°C increments per hour from90°C to45°C, at which temperature it was kept
for the subsequent steps. The tissue samples were then washed several times with
anhydrous methanol to remove residual water and uranyl acetate. The infiltra-
tion in Lowicryl resin HM20 went stepwise from Lowicryl-methanol 1:2, 1:1, and
2:1 (1 h each) to pure Lowicryl (overnight). For polymerization, the tissue was
placed in a precooled embedding mall, and the polymerization was catalyzed by
UV light of 360 nm wavelength for 2 days at 45°C, followed by 1 day at room
temperature. Ultrathin sections (90 nm) were cut by a diamond knife on a
Reichert-Jung ultramicrotome and mounted on nickel grids using an adhesive
pen (Electron Microscopy Sciences).
The ultrathin sections were contrasted in uranyl acetate (5%) and lead citrate
(30%). Sections were observed in a Philips CM100 electron microscope. Pictures
were taken at primary magnifications of 25,000.
Quantitative electron microscopic analysis. Electron micrographs with clearly
visible synapses were taken randomly in the stratum radiatum of CA1, 10 m
apical to the pyramidal cell layer. The excitatory synapses were identified as small
terminals forming asymmetric synaptic specializations on dendritic spines (Schaf-
fer collateral synapses). The lengths (in nanometers) of the postsynaptic mem-
branes of excitatory synapses were recorded (6) in mutUNG1-expressing mice
and wild-type littermates. The lengths of postsynaptic membranes were also
recorded at synapses between excitatory parallel fiber and Purkinje cell dendritic
spines in the molecular layer of the cerebellum in mutUNG1-expressing mice
and wild-type littermates. Mice were induced for 7 to 8 months.
Behavior. Open field tests were conducted using a VersaMax animal activity
monitoring system (AccuScan Instruments, Inc.). Two mice were measured si-
multaneously for 10 min, once a month. The tester was blind to the genotypes,
and the mice were measured in random order. Twenty mice (eleven mutUNG1-
expressing mice and nine wild-type littermates) were used in this experiment.
The data were analyzed by using VersaDat software (AccuScan Instruments,
Inc.).
The Morris water maze task was conducted in a white circular tank, 120 cm in
diameter and 30 cm deep, filled with 20 cm of white opaque water (SikaLatex
liquid) that was maintained at 24 	 1°C. A pneumatically controlled escape
platform 11 cm in diameter was located at a fixed position midway between the
center and the wall. The platform was usually 1.0 cm below the water surface, but
on Atlantis and probe trials the platform was submerged to the bottom; during
the Atlantis tests, this was only for the first 40 s. The experimenter sat in a fixed
position 2 m from the pool and was visible to the animals during the task.
Training in the Morris water maze consisted of eight blocks of four trials. The
mice were given two blocks of trials per day with an interblock interval of 3 h.
The first trial of the first block each day was an Atlantis trial. The start position
for each trial was randomly drawn from four possible positions. The mice were
released into the water with their heads facing the maze wall and were given a
maximum of 60 s to locate the hidden platform. The mice remained on the
platform for 15 s after each trial. Retention tests, or probe trials, with the escape
platform submerged to the bottom of the pool, were conducted on days 5 and 11.
The test order was randomized (50). For thigmotaxis measurements, the thig-
motaxis zone was extended 20 cm form the wall into the pool. Twelve mice (six
mutUNG1-expressing mice and six wild-type littermates) were used in this ex-
periment. The position of the mice was tracked and stored at 10 Hz by a video
tracking system (Any-Maze, Stoelting, IL).
The zero-maze task (44) was conducted in a custom-made apparatus consisting
of a white 5-cm-wide circular runway with an inner diameter of 50 cm and
elevated 65 cm above the floor. The runway had alternating open and closed
quadrants. The closed quadrants had a metal outer wall and a transparent inner
wall of 20-cm height. The open quadrants had a 1-cm-high lip along the inner and
outer edges to prevent the mice from falling off the runway.
Testing took place under 110 lx of illumination recorded at the level of runway
in both open quadrants. The test order was randomized. The mice were placed
on the maze facing a closed quadrant and allowed 5 min for exploration of the
apparatus. The position of the mice was tracked and stored at 10 Hz by a video
tracking system, and the number and duration of head dips was manually re-
corded in the tracking software. An open area entry was defined as 85% of the
mouse inside an open area. Twelve mice (six mutUNG1-expressing mice and six
wild-type littermates) were used in this experiment.
Statistical analysis. All quantitative date are represented as means 	 the
standard error of the mean. Unpaired, two-tailed t tests were performed unless
otherwise stated. The null hypothesis was rejected at the 0.05 level.
RESULTS
Characterization of the CaMKII-inducible mutUNG1
mouse model. The present study was initiated to explore the
influence of mtDNA damage in the forebrain neurons of mice,
particularly in association with behavioral defects, aging, and
associated diseases. We wanted to investigate the impact of
mtDNA damage and have addressed this by producing trans-
genic mice expressing a mutated mitochondrion-targeted DNA
repair enzyme. The enzyme is an engineered modification of
human UNG1 (Y147A; mutUNG1) that catalyzes the removal
of thymine from DNA in addition to uracil (23). Thus,
mutUNG1 induces DNA damage in the form of AP sites. In
contrast to the endogenous murine Ung1 protein, which is
transported both to the nucleus and to the mitochondria (36),
human UNG1 used in the present study is sorted exclusively to
the mitochondria (39). We used the Tet-on system combined
with the CaMKII promoter to restrict mutUNG1 expression
to forebrain neurons in the adult mouse brain (5, 34). The
mutUNG1 gene was cloned into a vector containing a bidirec-
tional Tet on promoter (4). In this vector, luciferase was coex-
pressed with mutUNG1 and used as a reporter gene (Fig. 1a and
b). To test the inducible potential of mutUNG1 and luciferase,
the construct was transfected into Tet-on stable transfected
cells and induced by the addition of doxycycline. Reporter
expression was confirmed by luminometer analysis (data not
shown), and increased levels of UNG1 (consisting of the
endogenous murine Ung1 and the transgene expressed
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mutUNG1) were confirmed by Western analysis (Fig. 1c).
Twelve transgenic founder mice were made by using pro-
nuclear injection of the Tet-on luciferase/mutUNG1 DNA
construct, and these were bred with rtTA2-mice (34). Founder
I was picked for continual studies based on its high and specific
luciferase activity (Fig. 1d). Expression of the mutUNG1 was
also confirmed by RT-PCR (Fig. 1e). The CaMKII promoter
is forebrain specific, and the expression in the hippocampus
and caudate putamen is severalfold higher than that in the
cerebellum (34). The presence of the genes for luciferase,
mutUNG1 and the transactivator from the Tet-on system,
rtTA2, was also confirmed by genotyping (data not shown).
The mutUNG1 mice started to show severe signs of sickness
between 5.5 and 8.5 months of doxycycline induction (Fig. 1f):
they were generally very restless and showed erratic behavior
with exaggerated scratching that eventually led to open
wounds, especially in areas of the body that they could reach
easily, such as the backs of their heads and behind the ears.
Therefore, it was no longer ethically correct to keep the mice
alive.
FIG. 1. Verification of the CaMKII-inducible mutUNG1 mouse model. (a) Construct design for the generation of mutUNG1 inducible mice.
(b) Working model of the transgenic mouse. (c) Western analysis showing increased expression of UNG1 in stable transfected cells. Antibodies
against mitochondrial complex II were used as a loading control. (d) Luciferase activity measured with a charge-coupled device camera in
transgenic founder mouse. Bioluminescence is expressed as photons/s cm2 steradian. (e) Expression of mutUNG1-transgene analyzed by using
reverse transcriptase PCR visualized on an agarose gel. Cb, cerebellum; Hip, hippocampus; Cpu, caudate putamen. (f) Survival of wild-type (black)
and mutUNG1-expressing mice (red).
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Wild-type mice that were on a diet containing doxycycline
and mutUNG1 mice that were fed with normal food without
doxycycline (and thereby not expressing mutUNG1) resembled
the wild-type littermates and did not exhibit the phenotype of
the mutUNG1-expressing mice.
Activity of mutUNG1 in transgenic mice. The activity of
mutUNG1 was analyzed in protein extracts from hippocampus,
caudate putamen, and cerebellum from induced mutUNG1
mice and wild-type littermates. Enzymatic activities were ana-
lyzed from the amount of incised thymine or uracil residues
after cleavage of the resulting intermediate AP site with NaOH
and heat (Fig. 2a to c) (24). A fivefold increase in UDG activity
was revealed in hippocampal extracts in mutUNG1-expressing
mice compared to wild-type littermates (P  0.0001). There
was a more moderate increase, twofold, in the caudate puta-
men (P 
 0.0133). Whereas significant thymine removal activ-
ity was registered for induced hippocampus and, to a lesser
extent, in the caudate putamen in mutUNG1-expressing mice,
no activity was observed in extracts from wild-type littermates
or in induced cerebellum (Fig. 2c). Thus, all detectable thy-
mine removal appears to be associated with expression of
mutUNG1. This is expected, since no endogenous protein is
capable of removing thymine from normal T:A base pairs.
Consequences of mutUNG1 expression for mitochondrial
function. In order to analyze the functional consequence of
mutUNG1 expression, the respiratory activity of mitochondria
from mutUNG1-expressing mice and wild-type littermates was
measured using an oxygraph. We aimed to quantify the respi-
ratory capacity of individual mice, omitting pooling. Mitochon-
dria from different brain subregions from single mice were
isolated and analyzed by high-resolution respirometry. The
low amounts of tissue, especially for the hippocampus and
caudate putamen, means that we were on the threshold for the
oxygraph to register data and measure respiratory activity. As
seen (Fig. 2d and e), the hippocampal mitochondria displayed
lower activity, during both complex I- and II-supported respi-
ration. This indicates reduced electron transport chain activity
in the hippocampal region, whereas no change was observed
for the cerebellum or caudate putamen.
Previously, targeting of the proofreading domain of the
mtDNA polymerase gamma was reported to increase the fre-
quency of the mtDNA point mutation up to 2,500-fold (48).
However, our mice (expressing mutUNG1) have mutation fre-
quencies that are undistinguishable from wild-type littermates.
In all tissues tested—hippocampus, caudate putamen, and cer-
ebellum—the frequencies of mutations were always less than
1.2  105 (7.4  104 to 8.5  104 bases were sequenced for
each tissue sample with three mice in each group).
However, mtDNA from the hippocampus of mutUNG1-
expressing mice was characterized by highly elevated levels of
AP sites compared to wild-type littermates. This was obtained
by utilizing an aldehyde-reactive probe, which reacts with the
exposed aldehyde group formed at AP sites (Fig. 3a). In the
cerebellum, in which mutUNG1 was not expressed, we did not
detect an increased level of AP sites. It is worth noticing that
AP sites in the hippocampus were completely excluded from
the nuclei, highlighting the specific export of mutUNG1 to the
mitochondria (Fig. 3b). This corresponds well with the ele-
vated UDG and thymine removal activity (Fig. 2b and c). The
lack of mutations is likely due to the existence of enzymes that
accurately complete the later stages of BER in mitochondria
or, alternatively, the lack of mammalian polymerases for trans-
lesion synthesis in mitochondria (42, 52). Thus, our model
visualizes the effect of mtDNA damage rather than mtDNA
mutations.
Apoptosis and progressive atrophy in the hippocampus of
mutUNG1-expressing mice. Investigation of HE-stained coro-
FIG. 2. Activity and consequence of mutUNG1expression in trans-
genic mice. (a) Uracil and thymine removal activity was measured
using a 5-end radioactively labeled 31-mer oligonucleotide containing
either a single uracil or a single thymine residue placed at position 16
from the 5 terminus of the substrate and hybridized to a complemen-
tary strand. After incubation with tissue extracts, enzymatic activities
were analyzed from the amount of incised thymine or uracil residues
after cleavage of the resulting intermediate AP site with NaOH and
heat and strand separation by denaturating PAGE. Bands were visu-
alized and quantified by using a Typhoon 9410 and ImageQuant TL
v2003.02 software (Amersham/GE Healthcare). (b) Uracil removal
activity is highest in induced brain areas in mutUNG1 mice. (c) Thy-
mine removal activity is only present in induced brain areas in
mutUNG1 mice. , no activity was identified. (d) Oxygraph measure-
ments indicating reduced mitochondrial respiration capacity in com-
plex I in the hippocampus of mutUNG1-expressing mice compared to
wild-type littermates. (e) Oxygraph measurements indicating reduced
mitochondrial respiration capacity in complex II in the hippocampus of
mutUNG1 expressing mice compared to wild-type littermates. Cb,
cerebellum; Hip, hippocampus; Cpu, caudate putamen.
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nal brain sections revealed progressive atrophy and severe
shrinkage of the hippocampus in mutUNG1-expressing mice
(illustrated at 2, 4, and 8 months of age in Fig. 4a). Atrophy of
the human hippocampus has been seen in a variety of psychi-
atric and neurological disorders, such as Cushing’s syndrome,
recurrent depression, schizophrenia, posttraumatic stress dis-
order, epilepsy, head injury, and normal aging preceding de-
mentia and Alzheimer’s disease (13, 33). Rough estimates, by
measuring the distance from the back of the dentate gyrus over
the stratum radiatum until CA1, show a shrinkage of the hip-
pocampus of 25% in mice induced for 2 months, 40% in
mice induced for 4 months, and 45% in mice induced for 8
months, compared to the wild-type littermates.
To investigate the atrophic effect in the hippocampus fur-
ther, cryosections were immunostained. Microtubule-associ-
ated protein 2 (MAP2) was used as a neuronal marker and
glial fibrillary acidic protein (GFAP) as a glial cell/astrocyte
marker (Fig. 4b). An apparent mutUNG1-dependent progres-
sive reduction in nerve cells was identified in the hippocampus
but not in caudate putamen (Fig. 4b). Using a TUNEL assay
on cryosections, we found a high degree of apoptosis in
mutUNG1-expressing hippocampus. The level of apoptosis
peaked at 3 months of induction and might reflect the re-
duced number of cells in mutUNG1-expressing hippocampus
at later stages. A more modest level of apoptosis was observed
at later time points, at 5 months postinduction, in caudate
putamen (Fig. 4c).
Electron microscopy reveals neurodegeneration and re-
duced membrane length of the postsynaptic density on den-
dritic spines from hippocampal CA1 pyramidal cells. Analysis
of hippocampal sections from mutUNG1-expressing mice by
electron microscopy revealed signs of neurodegeneration (Fig.
5a), while in the cerebellum—a tissue in which the CaMKII
promoter is not active—we found no morphological differ-
ences when comparing mutUNG1-expressing mice and wild-
type littermates (Fig. 5b). Closer inspection of the Schaffer
collateral synapses and measurements of the membrane length
of the postsynaptic densities (PSD) on dendritic spines of CA1
pyramidal cells revealed a reduction in the PSD size in
mutUNG1-expressing mice (P  0.02, Mann-Whitney test)
(Fig. 5c). When the same measurements of the membrane
length of the PSD at parallel fiber-Purkinje cell synapses were
made in the cerebellar molecular layer, no significant differ-
ence was observed between mutUNG1-expressing mice and
the wild-type littermates (Fig. 5d). The PSD, a highly complex
protein network consisting of hundreds of different proteins, is
believed to be an important part of the structural basis for
learning and memory formation (7). Thus, a reduction in PSD
size in CA1 pyramidal cells is likely to influence these pro-
cesses in mutUNG1-expressing mice and may ultimately affect
the ability to learn and form new memories.
Electron microscopy showed no significant difference in the
number of mitochondria between mutUNG1-expressing mice
and wild-type littermates, leading us to speculate that the ob-
served phenotype is due to poorly functioning mitochondria
rather than to reduced numbers of the organelle.
Behavioral tests reveal increased locomotor activity, but
decreased cognitive ability and anxietylike behavior, in
mutUNG1-expressing mice. Locomotion and exploratory ac-
tivity of mutUNG1-expressing mice were tested in an open
field. We observed a general decline in exploration with time
for both mutUNG1-expressing mice and controls but a relative
increase in exploration in mutUNG1-expressing mice com-
pared to controls. Thus, there were significant differences be-
tween the mouse groups in the total distance traveled and
number of rearings (Fig. 6a and b). Compared to littermate
FIG. 3. AP site appearances in mutUNG1-expressing mice. (a)
Coronal cryosections of the hippocampus and cerebellum probed with
an aldehyde-reactive probe and stained with DAPI demonstrate a high
level of AP sites, but only in the hippocampus of induced mutUNG1
mice. Scale bar, 100 m. (b) AP sites are only seen in parts of the
hippocampus containing mitochondria, not nuclei, as demonstrated
here in a mutUNG1 mouse induced for 3 months. Scale bar, 25 m.
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controls, mutUNG1-expressing mice showed a threefold in-
crease in the total distance traveled after 6 months of doxycy-
cline administration (mice were induced from 2 months of age
so they are 8 months old, P  0.0001). However, repeated
measurements between 2 and 6 months of induction showed a
long-term 1.5-fold decrease in the total distance traveled for
mutUNG1-expressing mice (P 
 0.0015) and a 3.8-fold de-
crease for wild-type littermates (P  0.0001) (Fig. 6a). Com-
pared to littermate controls, analysis of rearing movements
showed a 4.5-fold increase in mutUNG1-expressing mice after
6 months of doxycycline administration (8 months old, P 
0.0001). However, between the second and sixth months of
induction, there was a 1.4-fold decrease in rearing movements
for the mutUNG1-expressing mice (P 
 0.0161) and a 3.7-fold
decrease for the control mice (P  0.0001) (Fig. 6b).
Given the observed morphological and anatomical changes
in the hippocampus, we investigated whether mutUNG1 ex-
pression affected spatial learning and memory performance in
the Morris water maze. This was of particular interest since the
Morris water maze measures activities that strongly correlate
with hippocampal plasticity and long-term potentiation, and it
has previously been shown that memory loss in old rats is
associated with brain mitochondrial decay and DNA/RNA ox-
idation (29, 50). Compared to littermate controls, mutUNG1-
expressing mice tended to spend less time searching inside the
target quadrant for the submerged platform during the probe
trials (P 
 0.036, repeated-measures analysis of variance, and
P 
 0.043, Mann-Whitney test, for both probe trials pooled)
(Fig. 6c) were and inclined to spend less time close to the pool
wall (P 
 0.005, Mann-Whitney test) (Fig. 6f). Furthermore,
although no significant effect of treatment was observed (P 

0.079, repeated-measures analysis of variance), analysis of the
escape latencies during the learning trials also suggested that
the mutUNG1-expressing mice were poorer learners than the
wild-type littermates (Fig. 6g). These results indicate that mu-
tUNG1-expressing mice have a learning or memory deficit and
a reduced anxietylike response.
Based on the observed thigmotaxis in the water maze (Fig. 6f),
we wanted to investigate anxietylike behavior in mutUNG1 ex-
pressing mice in the elevated zero maze. Compared to littermate
FIG. 4. Induced mutUNG1 mice show progressive atrophy, neuronal loss, and apoptosis in the hippocampus. (a) HE-stained coronal paraffin
sections of hippocampus of wild-type and mutUNG1-expressing mice at different time points of induction show progressive atrophy in induced
mutUNG1 mice. (b) Immunostained coronal cryosections of hippocampus and caudate putamen incubated with antibodies against neuronal
marker MAP2 and astrocyte marker GFAP in addition to DAPI stain reveal neuronal loss in hippocampus of induced mutUNG1 mice. (c) TUNEL
(and DAPI) staining of cryosections of wild-type and mutUNG1-expressing mice at different time points of induction reveal a high degree of
apoptosis in the hippocampus, but not in caudate putamen, in induced mutUNG1 mice. Scale bars, 100 m.
VOL. 30, 2010 mtDNA TOXICITY IN FOREBRAIN NEURONS 1363
FIG. 5. Neurodegeneration and reduced membrane length of the postsynaptic density on dendritic spines from mutUNG1-expressing CA1
pyramidal cells. Electron micrographs showing examples of terminals making asymmetric (i.e., excitatory) synapses with dendritic spines in
wild-type and mutUNG1-expressing mice in CA1 stratum radiatum of hippocampus (a) and in the cerebellar molecular layer (b). Note the small
size of the tissue profiles, including a short length of the PSD (arrowheads), in the mutUNG1-expressing hippocampus. The following structures
are indicated: axon terminal (terminal), postsynaptic spine (spine), ends of PSD (arrowheads), mitochondria (m), parallel fiber-Purkinje cell
synapses (Pft), and stem dendrite. Scale bars, 150 nm. (c) Histograms showing the mean PSD length	 the standard deviation of excitatory synapses
in and four mutUNG1-expressing mice and four wild-type littermates in CA1 stratum radiatum of hippocampus (c) and the cerebellar molecular
layer (d). , the PSD values in all hippocampal mutUNG1-expressing mice were significantly lower than those in wild-type littermates (P  0.02).
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controls, mutUNG1-expressing mice made more entries into
(P 
 0.024, Mann-Whitney test) and spent a greater percentage
of the time (P 
 0.005, Mann-Whitney test) in the open areas
(Fig. 6h, i, and j). These data indicate that the mutUNG1-express-
ing mice have reduced anxietylike behavior compared to wild-
type littermates.
DISCUSSION
mutUNG1-expressing mice are characterized by a dramatic
increase in the steady-state level of cytotoxic AP sites in
mtDNA. However, no increase in the mutation frequency
could be detected. Possibly, AP sites, which are common in-
FIG. 6. Increased locomotor activity, but decreased cognitive ability and anxietylike behavior, in mutUNG1-expressing mice. (a) Mice
expressing mutUNG1 show higher locomotor activity in the form of total distance traveled in open field tests compared to wild-type littermates.
(b) MutUNG1-expressing mice show higher activity in the form of rearing movements in open field tests compared to wild-type littermates. (c)
Percentage of time spent in each of the four quadrants of the water maze during probe trials. The mutUNG1 mice spend less time in the target
quadrant than the wild-type littermates. The results from both probe trials have been pooled. (d) Representative swimming paths in the water maze
during the probe trial on day 5. (e) Percentage of time spent in the target quadrant of the water maze for both probe trials. (f) Percentage of time
in thigmotaxis (that is, the tendency of rodents to hug the wall) during the water maze test. (g) Latency to locate platform position during the
learning phase of the water maze task. (h) Entries to the open areas of the elevated zero maze. Induced mutUNG1 mice show reduced anxiety
responses by a higher entry frequency into the open areas. (i) Percentage of time in the open areas of the elevated zero maze. Induced mutUNG1
mice show reduced anxiety responses by spending more time in the open areas. (j) Representative paths of the head during the elevated zero maze
task. Closed quadrants are marked with double lines.
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termediates in BER of all types of base lesions, are eventually
processed in an error-free manner by the multistep mitochon-
drial BER pathway (12) or, alternatively, AP sites containing
mtDNA are disfavored during replication. DNA damage that
is generally reparable by BER is efficiently repaired in mtDNA,
whereas mtDNA damage that requires another sort of repair
machinery is not (8). AP sites that remain in DNA present a
serious threat to the genome by presenting a block to the
replicative polymerases. In order to overcome the toxicity of
such replication blocks, a set of translesion synthesis poly-
merases have evolved. Some of these DNA polymerases rep-
licate through the AP site in an error-prone manner. AP sites
are noninstructional DNA lesions, and any replication through
them are highly mutagenic. In prokaryotes and yeast and mam-
malian cells an adenine is predominantly inserted opposite an
AP site, probably because this confers the least amount of helix
distortion, and this has been termed the “A rule” (3, 40, 46).
Even though mitochondrial transport of the translesion syn-
thesis components polymerase zeta and Rev1p in Saccharomy-
ces cerevisiae has been demonstrated (52), the only known
polymerase in mammalian mitochondria is the replicative poly-
merase gamma (42). Thus, we propose that the phenotypes
observed here are caused entirely by the increase in cytotoxic
AP sites. Previous studies in cell cultures have provided evi-
dence that the capacity of the BER pathway for handling AP
sites after oxidative stress correlates strongly with mitochon-
drial initiated apoptosis and neurodegeneration (20). Targeted
damage of the DNA structure is considered to be a key ap-
proach in the induction of cell death and, among the plethora
of death execution programs, the mitochondrial events are of
the utmost importance (17, 21). Thus, a significant increase in
the number of mitochondrial AP sites could explain the severe
apoptosis in our aging colony of doxycycline-induced mice.
Similarly, endogenously generated AP sites cause cell death in
repair-deficient S. cerevisiae (18). A reduction in mitochondrial
respiration could also explain why mutUNG1-expressing cells
are more prone to undergo apoptosis (51). Similar to our data,
caloric restriction in mice, plus the overexpression of catalase
targeted to mouse mitochondria—two treatments that extend
the life span of mice—specifically decrease mitochondrial
DNA damage and inhibit stress-induced apoptotic cell death
(10, 43).
Neurodegenerative disease progression, caused by mito-
chondrial dysfunction, are often associated with apoptosis and
a progressive loss of neurons (41). In addition, defects in en-
ergy consumption have been found in Alzheimer’s disease,
Parkinson’s disease and Huntington’s disease (14, 15, 32). We
observed gross abnormalities and loss of neuronal tissue and
atrophy in the hippocampus of mutUNG1-expressing mice.
The integrity of the mtDNA is believed to be particularly
important for postmitotic tissue such as neurons, since mito-
chondria have a central role in synapses in that they provide
the energy required for synaptic activity, and dysfunction can
cause aberrant nerve function. The mutUNG1-expressing mice
also show differences in behavior compared to wild-type litter-
mates, such as increased locomotor activity and rearing in
open-field tests and reduced anxietylike responses in elevated
zero maze tests. These results demonstrate the severity and
toxicity of damage to mtDNA in the form of AP sites. In
contrast, mice expressing polymerase gamma carrying a de-
leted proofreading domain in forebrain neurons were charac-
terized by elevated levels of mtDNA point mutations and de-
letions, and such mice displayed a mood disorder. However,
degeneration in the brain or behavioral abnormalities were not
identified in these mice (22).
The PSD contains proteins that are essential for synaptic
transmission, and dynamic rearrangements of the PSD are
thought to contribute to synaptic regulation and plasticity, un-
derlying learning and memory formation (7). Therefore, the
reduced PSD size in CA1 pyramidal cells of mutUNG1-ex-
pressing mice is likely to influence synaptic transmission and
plasticity and may thus ultimately affect the ability to learn and
form new memories (9, 27). Hence, the memory deficits dis-
played by the mutUNG1-expressing mice is probably related to
both the observed hippocampal atrophy and the reduced PSD
size.
Finally, the mouse model created for the present study,
which carries a bidirectional doxycycline-responsive promoter
for simultaneous induction of mutUNG1 and luciferase,
should allow us to address the role of the mtDNA damage and
mitochondrial dysfunction in more or less any organs of the
mouse by using a different tissue specific promoter. In partic-
ular, mitochondria in cardiac cells are important for generating
energy, and mitochondria have been implicated in the loss of
cells in various cardiac pathologies, including ischemia/reper-
fusion and congestive heart failure (19).
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